Comparative genomic hybridization study of genetic changes associated with vindesine resistance in esophageal carcinoma.
The acquisition of drug-resistance is a major problem for cancer patients undergoing chemotherapy. To clarify genetic alterations in cancer cells that develop drug-resistance, comparative genomic hybridization (CGH) was applied to esophageal squamous cell carcinoma cell lines (SH-1V1, SH-1V2, SH-1V4 and SH-1V8) and chemoresistance-related genes in altered chromosomal regions were evaluated. These cell lines were derived from the parental SH-1 cell line, after multiple steps of selection by an increasing exposure to vindesine. SH-1V8 cells were strongly resistant to vindesine. DNA copy number at 16p which includes the MRP (multidrug resistance related protein) gene was markedly increased in all cell lines examined. Increased DNA copy numbers were found at the regions of 5q31-32, 10q11.1-23, and 14q32-qter in SH-1V8 cells that acquired resistance to other drugs as well. Both SH-1V4 and SH-1V8 showed increased DNA copy numbers at 7q11.1-22, 16q12.1-qter, 19p13.2-13.3, 19q11-13.2 and 20q13.1-qter. The chromosomal region of 7q11.1-22 including MDR-1 (multidrug resistance-1) gene was highly amplified in SH-1V4 and SH-1V8. Amplification of the MRP region suggests the prerequisite of developing resistance to vindesine, and further amplification of MDR-1 may play a critical role in acquiring drug-resistance. Several unknown genes related to the induction of chemoresistance might be concealed in other altered chromosomal regions.
Obara
Kunihiko
K
Center for Digestive Disease, Nippon Medical School Second Hospital, Kawasaki, Kanagawa 211-8533, Japan. obara@gd5.so-net.ne.jp
Ghazizadeh
Mohammad
M
Shimizu
Hajime
H
Arai
Ritsuko
R
Tenjin
Toshihiro
T
Suzuki
Seiji
S
Moriyama
Yukichi
Y
Kawanami
Oichi
O
D002869:Chromosome Aberrations; D002877:Chromosomes, Human / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000235:genetics*; D005784:Gene Amplification / Q000187:drug effects; D018628:Gene Dosage; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D052138:Genes, Neoplasm / Q000235:genetics; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008677:Metaphase / Q000235:genetics; D009693:Nucleic Acid Hybridization; D020161:Physical Chromosome Mapping; D014407:Tumor Cells, Cultured; D014751:Vindesine / Q000494:pharmacology*
D014751:Vindesine